ANNA-BIOSCIENCES
22.6.2021 15:02:10 CEST | Business Wire | Press release
Anna Biosciences, a drug discovery company focused on novel therapies in immuno-oncology, virology, and neurodegenerative diseases, today announces its entry in the fight against COVID-19 with the introduction of its immunotherapy platform, Syntem.
The Anna Biosciences Syntem Platform deploys engineered proprietary molecules to create synthetic immunity. Syntem’s lab-made molecules are multi-specific: they first target and flag the pathology, and then elicit an immune reaction that targets the virus or disease.
Research indicates the Syntem Platform can inhibit viral infection and aid in the removal of COVID-19 infected cells. Showing promise as both a prophylactic and a treatment, there is considerable hope that in addition to supporting the broader population, immunocompromised patients will be able to safely use Syntem to prevent infection. Importantly, Syntem also exhibits high potential against COVID variants. In the case of COVID-19, and coronaviruses more generally, the Syntem Platform represents a significant new tool in the arsenal against these rapidly evolving diseases.
With today’s announcement, Anna Biosciences underscores both its initial successes in the lab and the successful patenting of the Syntem Platform. The company is now accelerating its commercialization effort to bring this potential COVID-19 treatment to market.
The Syntem Platform also shows strong promise for use against cancer and other pathogens. Research into the application of Syntem for oncological targets is currently underway. The resulting therapies could offer precision targeting, and the potential to mitigate side effects while being easier to administer to patients.
“Like vaccines in the 20th century, synthetic small molecule immunotherapy is on the precipice of advancing human health in untold ways. A powerful new tool is on the horizon in our fight against coronaviruses. And that’s just the beginning of this technology’s potential,” said Dr. Anthony Rullo, a scientific co-founder of Anna Biosciences and assistant professor of medicine at McMaster University in Ontario, Canada. “I’m extremely proud of our team, and the extraordinary effort of everyone involved at Anna Biosciences in the furthering of this technology.”
About Anna Biosciences
Anna Biosciences is a drug discovery company that uses decentralized partnerships to develop and advance new therapies for better patient outcomes. Anna Biosciences’ first initiative, the Syntem Platform, is developing proprietary molecules to trigger synthetic immunity for COVID-19 and beyond.
Anna Biosciences will continue to develop the Syntem Platform modality for additional therapies for a range of diseases. The company is currently working on the implementation of this approach to activate immune cells that can recognize and attack cancers.
For more information, visit http://annabiosciences.com/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210622005353/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incode Acquires Identiq to Expand Its Privacy-First Architecture for Identity and Fraud Prevention25.6.2026 15:00:00 CEST | Press release
Extends its privacy-by-design architecture with Identiq’s patented cryptographic technology that enables organizations to share fraud signals without sharing sensitive data. Incode Technologies, a global leader in AI-powered identity verification and fraud prevention, today announced that it has completed the acquisition of Identiq, a company specializing in privacy-enhancing cryptographic solutions for peer-to-peer anti-fraud collaboration. Incode announced this acquisition as part of a $100 million commitment to advancing its original privacy-preserving identity infrastructure. The funds will be used to enhance on-device processing capabilities, continue R&D in privacy-enhancing technologies, and expand engineering resources and its global footprint. “We have always believed that privacy and fraud prevention are not a tradeoff, but part of the same problem, solved together or not at all,” said Ricardo Amper, Founder and CEO of Incode. “Identiq is the piece that enhances our Privacy b
Gurobi Introduces New Optimization Game Set in a Fast-Paced Coffee Shop25.6.2026 15:00:00 CEST | Press release
Gurobean, companion to the “Burrito Optimization Game” with 85,000+ plays, introduces advanced concepts like nonlinearity and uncertainty. Gurobi Optimization, LLC, the leader in decision intelligence technology, today announced the launch of Gurobean: The Coffee Optimization Game, a new educational game that brings nonlinearity, simulation, and decision-making under uncertainty to life. Following the success of the Burrito Optimization Game—which has been played over 85,000 times by learners across the world since its launch in 2022—Gurobean places players behind the counter of a virtual coffee shop, where they must make critical decisions around pricing, staffing, queue management, inventory levels, and more. The free, interactive game furthers Gurobi’s ongoing commitment to open education, teaching players: The value of mathematical optimization How quickly real-world decision problems become too complex to solve by trial and error How nonlinearity and uncertainty make outcomes hard
AllUnity and Zebec Deploy EURAU-Powered Employee Benefits and Enterprise Payment Solutions on Stellar25.6.2026 14:59:00 CEST | Press release
AllUnity and Zebec today announced the launch of an EURAU-based employee benefits and enterprise payments program on the Stellar network. The pilot program aims to expand payroll and workforce payments in AllUnity's regulated euro stablecoin across its ecosystem, including its major enterprise clients and partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625883682/en/ Built on Stellar and powered by EURAU, AllUnity's regulated euro stablecoin, the program combines regulated digital currency with enterprise grade payroll and payments infrastructure purpose built for global value transfer. Employees participating in the pilot can receive benefits directly to digital wallets while accessing a growing range of spending, savings, and payment options through the Zebec platform. "Regulated stablecoins are increasingly moving from financial infrastructure to real world business applications," said Simon Babakhani, CEO of Z
2026 Esri User Conference to Focus on Creating a More Intelligent World with GIS25.6.2026 14:00:00 CEST | Press release
More Than 18,000 Attendees Expected for World's Largest GIS Conference in San Diego The 2026 Esri User Conference will be held from July 13 to 17 in San Diego, California. This year's theme is "GIS—Creating a more intelligent world." Jack Dangermond, president and founder of Esri, and Kristine Tompkins, president and cofounder of Tompkins Conservation, will be the keynote speakers in the Plenary Session. Esri, the global leader in geographic information system (GIS) technology, today announced speakers and the conference theme for the 2026 Esri User Conference. The conference will be held from July 13 to 17 at the San Diego Convention Center in San Diego, California. This year's theme of "GIS—Creating a more intelligent world" will emphasize how GIS turns the science of "where" into shared understanding and coordinated action—at the scale of communities, enterprises, and the planet. Kristine Tompkins, president and cofounder of Tompkins Conservation, will join Esri president Jack Dange
Copeland Releases FY2025 Global Impact Report Highlighting Energy Efficiency, Safety and Innovation Progress25.6.2026 14:00:00 CEST | Press release
Scope 1 and Scope 2 greenhouse gas emissions declined nearly 20%1Near-term reduction targets validated by the Science Based Targets InitiativeGlobal Total Recordable Incident Rate improved to 0.21, outperforming the industry average by over 90% Copeland, a global leader in compression technologies and controls solutions, has released its second annual Global Impact Report. The report highlights the company’s Fiscal Year 2025 (FY25) progress across environmental sustainability, workplace safety and community impact, guided by its Purpose, Performance and People pillars. Copeland has advanced its sustainability commitments through three strategic areas of focus: Performance-Driven Decarbonization: Copeland reduced Scope 1 and Scope 2 greenhouse gas emissions by 20% year-over-year, advancing toward its Science Based Targets initiative (SBTi)-validated goal of a 55% absolute reduction by FY33, using FY23 as a baseline.2 Renewable energy procurement and onsite solar generation accounted for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom